Alzheimer's Disease Neuroimaging Initiative. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve

Inserm, Imagerie cérébrale et handicaps neurologiques UMR 825, F-31059 Toulouse, France.
Brain (Impact Factor: 9.2). 05/2009; 132(Pt 8):2036-47. DOI: 10.1093/brain/awp105
Source: PubMed


Brain atrophy measured by magnetic resonance structural imaging has been proposed as a surrogate marker for the early diagnosis of Alzheimer's disease. Studies on large samples are still required to determine its practical interest at the individual level, especially with regards to the capacity of anatomical magnetic resonance imaging to disentangle the confounding role of the cognitive reserve in the early diagnosis of Alzheimer's disease. One hundred and thirty healthy controls, 122 subjects with mild cognitive impairment of the amnestic type and 130 Alzheimer's disease patients were included from the ADNI database and followed up for 24 months. After 24 months, 72 amnestic mild cognitive impairment had converted to Alzheimer's disease (referred to as progressive mild cognitive impairment, as opposed to stable mild cognitive impairment). For each subject, cortical thickness was measured on the baseline magnetic resonance imaging volume. The resulting cortical thickness map was parcellated into 22 regions and a normalized thickness index was computed using the subset of regions (right medial temporal, left lateral temporal, right posterior cingulate) that optimally distinguished stable mild cognitive impairment from progressive mild cognitive impairment. We tested the ability of baseline normalized thickness index to predict evolution from amnestic mild cognitive impairment to Alzheimer's disease and compared it to the predictive values of the main cognitive scores at baseline. In addition, we studied the relationship between the normalized thickness index, the education level and the timeline of conversion to Alzheimer's disease. Normalized thickness index at baseline differed significantly among all the four diagnosis groups (P < 0.001) and correctly distinguished Alzheimer's disease patients from healthy controls with an 85% cross-validated accuracy. Normalized thickness index also correctly predicted evolution to Alzheimer's disease for 76% of amnestic mild cognitive impairment subjects after cross-validation, thus showing an advantage over cognitive scores (range 63-72%). Moreover, progressive mild cognitive impairment subjects, who converted later than 1 year after baseline, showed a significantly higher education level than those who converted earlier than 1 year after baseline. Using a normalized thickness index-based criterion may help with early diagnosis of Alzheimer's disease at the individual level, especially for highly educated subjects, up to 24 months before clinical criteria for Alzheimer's disease diagnosis are met.

Download full-text


Available from: Isabelle Berry, Mar 07, 2014
56 Reads
  • Source
    • "CR is a theoretical concept proposing that certain lifetime experiences, including education, degree of literacy, and occupational attainment, increase the flexibility, efficiency , and capacity of brain networks, thereby allowing individuals with higher CR to sustain greater levels of brain pathology before showing clinical impairment [for a review, see Stern, 2009]. In support of the concept of CR, cross-sectional studies of individuals across the continuum of AD have reported greater levels of atrophy among individuals with higher CR compared to those with lower CR despite similar levels of cognitive functioning, suggesting that the effects of atrophy on cognition are reduced in individuals with higher reserve [Arenaza-Urquijo et al., 2013; Liu et al., 2012; Querbes et al., 2009; Reed et al., 2010; Sole-Padulles et al., 2009]. There have not, however, been any longitudinal investigations to determine whether individual differences in CR modify the relationship between structural MRI measures and risk of developing cognitive impairment among asymptomatic individuals. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study evaluated the utility of baseline and longitudinal magnetic resonance imaging (MRI) measures of medial temporal lobe brain regions collected when participants were cognitively normal and largely in middle age (mean age 57 years) to predict the time to onset of clinical symptoms associated with mild cognitive impairment (MCI). Furthermore, we examined whether the relationship between MRI measures and clinical symptom onset was modified by apolipoprotein E (ApoE) genotype and level of cognitive reserve (CR). MRI scans and measures of CR were obtained at baseline from 245 participants who had been followed for up to 18 years (mean follow-up 11 years). A composite score based on reading, vocabulary, and years of education was used as an index of CR. Cox regression models showed that lower baseline volume of the right hippocampus and smaller baseline thickness of the right entorhinal cortex predicted the time to symptom onset independently of CR and ApoE-ɛ4 genotype, which also predicted the onset of symptoms. The atrophy rates of bilateral entorhinal cortex and amygdala volumes were also associated with time to symptom onset, independent of CR, ApoE genotype, and baseline volume. Only one measure, the left entorhinal cortex baseline volume, interacted with CR, such that smaller volumes predicted symptom onset only in individuals with lower CR. These results suggest that MRI measures of medial temporal atrophy, ApoE-ɛ4 genotype, and the protective effects of higher CR all predict the time to onset of symptoms associated with MCI in a largely independent, additive manner during the preclinical phase of Alzheimer's disease. Hum Brain Mapp, 2015. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.
    Human Brain Mapping 04/2015; 36(7). DOI:10.1002/hbm.22810 · 5.97 Impact Factor
  • Source
    • "Cognitive reserve has been shown to be protective in other chronic disorders, Cognitive dysfunction in adult OSA 11 including Alzheimer's disease (Querbes et al., 2009). With the exception of the above study, no other published studies have considered cognitive reserve when exploring the effects of OSA on cognition. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adult Obstructive Sleep Apnoea (OSA) is characterised by repeated, upper airway collapse resulting in sleep fragmentation and oxygen desaturation. Consequences of OSA include excessive daytime sleepiness, un-refreshing sleep, fatigue, increased risk of depression, reduced quality of life, and cognitive deficits. This article delineates the cognitive-and mood-related difficulties faced by individuals with OSA, discusses the theoretical accounts of nocturnal harm and daytime cognitive and mood dysfunction, and suggests practical tools to assess and treat psychological consequences of OSA.
    02/2015; 1(1). DOI:10.1037/tps0000021
  • Source
    • "Most of the earlier ROI based methods are based on manual segmentation of the region of interest. The features extracted in these techniques are usually tissue densities [18], cortical thickness [19] [20], and volume and shape of hippocampus [21] [22]. The limitation of such technique is that they do not show high sensitivity and specificity in diagnosis of individuals because of the complex pathology of AD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Structural brain imaging is playing a vital role in identification of changes that occur in brain associated with Alzheimer's disease. This paper proposes an automated image processing based approach for the identification of AD from MRI of the brain. The proposed approach is novel in a sense that it has higher specificity/accuracy values despite the use of smaller feature set as compared to existing approaches. Moreover, the proposed approach is capable of identifying AD patients in early stages. The dataset selected consists of 85 age and gender matched individuals from OASIS database. The features selected are volume of GM, WM, and CSF and size of hippocampus. Three different classification models (SVM, MLP, and J48) are used for identification of patients and controls. In addition, an ensemble of classifiers, based on majority voting, is adopted to overcome the error caused by an independent base classifier. Ten-fold cross validation strategy is applied for the evaluation of our scheme. Moreover, to evaluate the performance of proposed approach, individual features and combination of features are fed to individual classifiers and ensemble based classifier. Using size of left hippocampus as feature, the accuracy achieved with ensemble of classifiers is 93.75%, with 100% specificity and 87.5% sensitivity.
    Computational and Mathematical Methods in Medicine 09/2014; 2014:862307. DOI:10.1155/2014/862307 · 0.77 Impact Factor
Show more